Treating advanced prostate cancer: where are we, and where are we going?

Presenter: Dr. Sebastien Hotte
Original Date: Tuesday, July 26, 2016

Join Dr. Hotte as he:
  • Provides an overview of advanced prostate cancer and castrate resistant prostate cancer (CRPC)
  • Provides an overview of the treatment options if a man is first diagnosed with advanced prostate cancer
  • Provides an overview of the current treatment options for men who have developed CRPC
  • Discusses in general terms some possible future therapies, focusing specifically on clinical trials conducted in Canada
 

Dr. Sebastien Hotte's Biography:

Dr. Sebastien Hotte did his undergraduate training and went on to qualify as a physician at the University of Ottawa in 1996.  He pursued internal medicine at the University of Western Ontario in London, Canada and became a fellow of the Royal College of Physicians of Canada in 2000.  His subspecialty training was in Medical Oncology at Western and he received his certificate of special competence in 2001.  From 2001 to 2003, Dr. Hotte completed a clinical research fellowship in Developmental Therapeutics at the Juravinski Cancer Centre and obtained a Master’s Degree in Health Research Methodology from McMaster University.  Dr. Hotte is currently an Associate Professor in the Department of Oncology of McMaster University and is a staff oncologist at the Juravinski Cancer Centre.  One of his main research interests is in Developmental Therapeutics and Phase I trials and he is currently the Head of the Phase I Program at the Juravinski Cancer Centre.  He also has clinical and research interests in genito-urinary malignancies and serves as co-chair of the GU disease site group of the Cancer Care Ontario Program for Evidence Based Care (CCO-PEBC).  Lastly, he is active in the field of translational research and is the Principal Investigator and co-lead of the OICR-funded McMaster Oncology Translational Research Team.  Dr. Hotte has been appointed as a Scientist of the Escarpment Cancer Research Institute in Hamilton.  He is the principle or co-author of over 100 peer-reviewed articles and over 150 original abstracts and is the Principal or co-Principal Investigator on a number of grants totaling millions of dollars in funding.  First and foremost however, he is a husband and the proud father of two exceptional children, as well as a road cycling weekend warrior.

Expert AngleAbout Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   



Plaid for Dad


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More

Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved.
More


Click here for news archive